Indian pharma sector News

Inaugurating the 6th annual International Exhibition of Pharma and Healthcare (iPHEX), the Minister assured the global pharmaceutical players and regulators, of best quality and affordability of the Indian drugs.

The Indian pharmaceutical companies exhibit strong business profiles underpinned by good products and geographic diversity as compared to some global peers, American rating agency Moody`s said on Friday.

For drugs priced between Rs 20-50, the panel has proposal to cap the margin at 40 percent.

Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today

Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.

Calling for a shift in policy and regulation in pharma sector, government Tuesday stressed on the need for pharma industry to make quality medicines available to public at affordable rates.

The Sun Pharma-Ranbaxy transaction would create the country's largest pharmaceutical company.

The domestic pharmaceutical industry, which has been growing at a steady pace, faces the challenge of identifying the right talent and retaining them for long-term, experts have said.

Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.

Pharma sector, which has trade potential of USD 1.63 billion between India and Pakistan, can be an ideal area to improve bilateral relations, says a study by economic think-tank Icrier.